zynrelef
Generic: bupivacaine and meloxicam
Labeler: heron therapeutics, inc.Drug Facts
Product Profile
Brand Name
zynrelef
Generic Name
bupivacaine and meloxicam
Labeler
heron therapeutics, inc.
Dosage Form
SOLUTION
Routes
Active Ingredients
bupivacaine 200 mg/7mL, meloxicam 6 mg/7mL
Manufacturer
Identifiers & Regulatory
Product NDC
47426-503
Product ID
47426-503_44cabd7f-3a81-4749-b523-655d188b83cf
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA211988
Listing Expiration
2026-12-31
Marketing Start
2024-12-01
Pharmacologic Class
Established (EPC)
Mechanism of Action
Chemical Structure
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
47426503
Hyphenated Format
47426-503
Supplemental Identifiers
RxCUI
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
zynrelef (source: ndc)
Generic Name
bupivacaine and meloxicam (source: ndc)
Application Number
NDA211988 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 200 mg/7mL
- 6 mg/7mL
Packaging
- 1 CARTON in 1 KIT (47426-503-01) / 1 VIAL, SINGLE-DOSE in 1 CARTON (47426-503-03) / 2.3 mL in 1 VIAL, SINGLE-DOSE
Packages (1)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["INFILTRATION"], "spl_id": "44cabd7f-3a81-4749-b523-655d188b83cf", "openfda": {"nui": ["N0000000160", "M0001335", "N0000175722", "N0000175682", "M0000897", "N0000175976"], "unii": ["VG2QF83CGL", "Y8335394RO"], "rxcui": ["2560306", "2560308", "2560309", "2560311", "2560312", "2560315", "2560319", "2560321"], "spl_set_id": ["dab484a7-9353-43ba-9e74-7fab910c712b"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Amides [CS]"], "pharm_class_pe": ["Local Anesthesia [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Amide Local Anesthetic [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Heron Therapeutics, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 CARTON in 1 KIT (47426-503-01) / 1 VIAL, SINGLE-DOSE in 1 CARTON (47426-503-03) / 2.3 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "47426-503-01", "marketing_start_date": "20241201"}], "brand_name": "ZYNRELEF", "product_id": "47426-503_44cabd7f-3a81-4749-b523-655d188b83cf", "dosage_form": "SOLUTION", "pharm_class": ["Amide Local Anesthetic [EPC]", "Amides [CS]", "Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Local Anesthesia [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "product_ndc": "47426-503", "generic_name": "BUPIVACAINE and MELOXICAM", "labeler_name": "Heron Therapeutics, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ZYNRELEF", "active_ingredients": [{"name": "BUPIVACAINE", "strength": "200 mg/7mL"}, {"name": "MELOXICAM", "strength": "6 mg/7mL"}], "application_number": "NDA211988", "marketing_category": "NDA", "marketing_start_date": "20241201", "listing_expiration_date": "20261231"}